Altimmune: Is There Still Hope For Pemvidutide? I Believe There Is (Upgrade) (NASDAQ:ALT)

Altimmune, Inc.'s pemvidutide shows promise in weight loss and MASH but faces challenges. Click for my updated look at ALT and its competitive edge and potential.